This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AMN Healthcare (AMN) Unveils ShiftWise Flex Manager Hub App
by Zacks Equity Research
AMN Healthcare's (AMN) Manager Hub app, part of the ShiftWise Flex platform, revolutionizes workforce management for healthcare organizations with enhanced mobile capabilities and comprehensive insights.
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: AMN Healthcare (AMN)
by Tracey Ryniec
When will travel nurse demand return?
New Strong Sell Stocks for June 26th
by Zacks Equity Research
AMN, ALNT and DNZOY have been added to the Zacks Rank #5 (Strong Sell) List on June 26, 2024.
New Strong Sell Stocks for June 4th
by Zacks Equity Research
AMN, ARCB and ARW have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2023.
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Compared to Estimates, AMN Healthcare (AMN) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMN Healthcare Services (AMN) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.30% and 0.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for AMN Healthcare (AMN) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of AMN Healthcare (AMN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 30th
by Zacks Equity Research
AFCG, AAGIY and AMN have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2023.
New Strong Sell Stocks for April 22nd
by Zacks Equity Research
AMN, PRG and RKDA have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2024.
New Strong Sell Stocks for April 11th
by Zacks Equity Research
AMN, ACLS and GME have been added to the Zacks Rank #5 (Strong Sell) List on April 11, 2024.
Teladoc Health (TDOC) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc Health (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kaiser Aluminum and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Kaiser Aluminum and AMN Healthcare Services are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: AMN Healthcare Services (AMN)
by Shaun Pruitt
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services (AMN) stock despite the company's favorable long-term prospects.
AMN Healthcare (AMN) Expands Capabilities of ShiftWise Flex
by Zacks Equity Research
AMN Healthcare's (AMN) expansion of the capabilities of ShiftWise Flex is likely to enhance internal resource pool management for the healthcare system.
New Strong Sell Stocks for March 12th
by Zacks Equity Research
AMN, RCM and RC have been added to the Zacks Rank #5 (Strong Sell) List on March 12, 2024.
AMN Healthcare (AMN) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall fourth-quarter performance.
AMN Healthcare (AMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMN Healthcare Services (AMN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.76% and 1.89%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Stocks' Earnings Due on Feb 15: WST, ITGR & More
by Debanjana Dey
Medical Products companies' quarterly results are likely to reflect strength in customer demand. Let's see how ITGR, WST, AMN and PACB are placed ahead of their earnings releases.
What Analyst Projections for Key Metrics Reveal About AMN Healthcare (AMN) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of AMN Healthcare (AMN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.